HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gerd Geisslinger Selected Research

lecanoric acid

4/2022Lecanoric acid mediates anti-proliferative effects by an M phase arrest in colon cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gerd Geisslinger Research Topics

Disease

98Pain (Aches)
03/2022 - 01/2002
70Inflammation (Inflammations)
01/2022 - 03/2003
50Neoplasms (Cancer)
04/2022 - 04/2003
40Hyperalgesia
04/2020 - 10/2002
39Neuralgia (Stump Neuralgia)
03/2022 - 02/2004
20Hypersensitivity (Allergy)
01/2022 - 08/2005
13Chronic Pain
08/2021 - 06/2005
12Multiple Sclerosis
01/2021 - 12/2007
10Carcinoma (Carcinomatosis)
01/2021 - 07/2003
10Breast Neoplasms (Breast Cancer)
10/2020 - 11/2008
9Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
10/2018 - 06/2012
8Colonic Neoplasms (Colon Cancer)
04/2022 - 07/2003
8Infections
08/2021 - 05/2002
7Atherosclerosis
10/2019 - 07/2004
7Peripheral Nerve Injuries
10/2014 - 05/2010
6Alzheimer Disease (Alzheimer's Disease)
01/2022 - 12/2007
6Edema (Dropsy)
01/2021 - 03/2003
6Colitis
07/2019 - 02/2007
5Mental Disorders (Mental Disorder)
09/2021 - 06/2011
5Asthma (Bronchial Asthma)
01/2019 - 12/2007
5Fever (Fevers)
01/2018 - 07/2006
5Wounds and Injuries (Trauma)
06/2015 - 05/2003
5Hepatitis C
01/2015 - 01/2010
5Nausea
10/2013 - 01/2002
4Colorectal Neoplasms (Colorectal Cancer)
12/2020 - 04/2003
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2019 - 01/2017
4Osteoarthritis
07/2014 - 03/2003
4Myocardial Infarction
06/2012 - 01/2004
4Respiratory Insufficiency (Respiratory Failure)
09/2006 - 10/2003
3Type 2 Diabetes Mellitus (MODY)
01/2022 - 10/2008
3COVID-19
01/2022 - 01/2021
3Neurodegenerative Diseases (Neurodegenerative Disease)
08/2021 - 07/2004
3Autoimmune Diseases (Autoimmune Disease)
01/2021 - 04/2013
3Fibrosis (Cirrhosis)
01/2021 - 12/2014
3Acute Pain
12/2020 - 03/2007

Drug/Important Bio-Agent (IBA)

29LipidsIBA
01/2022 - 09/2007
28Pharmaceutical PreparationsIBA
03/2022 - 01/2002
24Analgesics (Analgesic Drugs)IBA
03/2022 - 01/2003
23Proteins (Proteins, Gene)FDA Link
08/2021 - 07/2004
23ZymosanIBA
01/2021 - 03/2003
18ProstaglandinsIBA
01/2022 - 05/2003
14CeramidesIBA
09/2021 - 05/2009
14Dinoprostone (PGE2)FDA Link
01/2021 - 05/2003
14EnzymesIBA
10/2020 - 09/2005
12Opioid Analgesics (Opioids)IBA
05/2013 - 01/2002
12Cyclooxygenase 2 (Cyclooxygenase-2)IBA
07/2011 - 04/2003
11Formaldehyde (Formol)FDA Link
01/2017 - 03/2003
10SphingolipidsIBA
09/2021 - 11/2008
10Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
11/2014 - 03/2003
10Celecoxib (Celebrex)FDA Link
12/2010 - 05/2003
10Morphine (MS Contin)FDA LinkGeneric
11/2010 - 10/2002
9Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2017 - 01/2004
8Reactive Oxygen Species (Oxygen Radicals)IBA
11/2021 - 01/2011
8CytokinesIBA
01/2021 - 07/2007
8Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2020 - 11/2006
8Epoxide HydrolasesIBA
01/2019 - 02/2009
8Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
10/2009 - 05/2003
7dihydroceramide desaturaseIBA
11/2021 - 06/2012
7Phosphotransferases (Kinase)IBA
11/2021 - 10/2008
7Messenger RNA (mRNA)IBA
10/2020 - 09/2011
7Capsaicin (Zostrix)FDA Link
04/2020 - 11/2008
7Biomarkers (Surrogate Marker)IBA
01/2019 - 02/2008
7Prostaglandins EIBA
04/2012 - 04/2008
6EndocannabinoidsIBA
09/2021 - 11/2007
6NF-kappa B (NF-kB)IBA
04/2010 - 04/2003
5Epoprostenol (Prostacyclin)FDA LinkGeneric
04/2022 - 05/2005
5Fingolimod Hydrochloride (FTY720)FDA Link
03/2022 - 02/2007
5G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2022 - 07/2013
5sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
09/2021 - 10/2007
5Cytostatic AgentsIBA
12/2020 - 12/2014
5Ion Channels (Ion Channel)IBA
12/2020 - 02/2011
5ThromboxanesIBA
01/2019 - 03/2007
5Antiviral Agents (Antivirals)IBA
10/2018 - 01/2010
5Flurbiprofen (Froben)FDA LinkGeneric
12/2016 - 07/2003
5Protein Isoforms (Isoforms)IBA
11/2016 - 04/2003
5GTP Cyclohydrolase (GTP Cyclohydrolase I)IBA
02/2013 - 11/2006
4Transcription Factors (Transcription Factor)IBA
08/2021 - 03/2007
4sphingosine kinaseIBA
01/2021 - 11/2008
4LipopolysaccharidesIBA
01/2021 - 01/2011
4ChemokinesIBA
12/2020 - 05/2012
4Protein Kinases (Protein Kinase)IBA
01/2019 - 03/2003
4Sphingosine-1-Phosphate ReceptorsIBA
01/2019 - 05/2009
4Fatty Acids (Saturated Fatty Acids)IBA
01/2019 - 11/2007
4Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA
10/2018 - 06/2014
4Cyclooxygenase InhibitorsIBA
03/2014 - 05/2003
4rofecoxib (Vioxx)FDA Link
10/2009 - 03/2003
4Cyclooxygenase 1IBA
08/2009 - 05/2003
4mu Opioid Receptors (mu Opioid Receptor)IBA
06/2009 - 01/2003
3Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2020
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 05/2008
3NucleosidesIBA
10/2021 - 05/2011
3Cytarabine (Cytosar-U)FDA LinkGeneric
10/2021 - 01/2017
3sapropterin (tetrahydrobiopterin)FDA Link
01/2021 - 11/2006
3Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2020 - 01/2017
3AntigensIBA
12/2020 - 04/2003
3Phospholipids (Phosphatides)FDA LinkGeneric
11/2020 - 01/2018
3anandamide (arachidonylethanolamide)IBA
10/2020 - 11/2007

Therapy/Procedure

43Therapeutics
04/2022 - 11/2002
10Drug Therapy (Chemotherapy)
01/2019 - 12/2014
7Analgesia
11/2013 - 05/2003